Alaunos Therapeutics Inc (TCRT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2009 | 06-2009 | 03-2009 | 12-2008 | 09-2008 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 7,080 | 4,543 | 6,768 | 11,379 | 15,192 |
| TOTAL | $7,450 | $4,696 | $7,006 | $11,706 | $15,769 |
| Non-Current Assets | |||||
| PPE Net | 324 | 406 | 489 | 489 | 589 |
| Other Non-Current Assets | 329 | 329 | 378 | 378 | 457 |
| TOTAL | $653 | $735 | $867 | $867 | $1,046 |
| Total Assets | $8,103 | $5,431 | $7,873 | $12,573 | $16,815 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,559 | 1,606 | 1,621 | 2,639 | 2,228 |
| Accrued Expenses | 1,909 | 1,730 | 2,298 | 3,137 | 3,473 |
| TOTAL | $3,514 | $3,375 | $3,956 | $5,776 | $5,701 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 46 | 39 | 37 | N/A | N/A |
| Other Non-Current Liabilities | 592 | 288 | 80 | 0 | 0 |
| TOTAL | $666 | $378 | $180 | $58 | $61 |
| Total Liabilities | $4,180 | $3,753 | $4,136 | $5,834 | $5,762 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 171 | 145 | 146 | 146 | 143 |
| Common Shares | 26 | 22 | 22 | 22 | 21 |
| Retained earnings | -92,108 | -89,233 | -86,833 | -85,061 | -80,498 |
| TOTAL | $3,923 | $1,678 | $3,737 | $6,739 | $11,053 |
| Total Liabilities And Equity | $8,103 | $5,431 | $7,873 | $12,573 | $16,815 |